Serial Number | 97331015 |
Word Mark | EPIGENOMIC PROGRAMMING |
Filing Date | Friday, March 25, 2022 |
Status | 602 - ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE |
Status Date | Monday, May 8, 2023 |
Registration Number | 0000000 |
Registration Date | NOT AVAILABLE |
Mark Drawing | 4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
Published for Opposition Date | NOT AVAILABLE |
Goods and Services | Pharmaceutical agents affecting DNA structure and/or epigenomic state by targeting DNA structure to treat various diseases; Pharmaceutical agents affecting DNA structure and/or epigenomic state by targeting DNA structure to treat various diseases in the nature of monogenic diseases, cancer, infectious disease, immune disease, hematological conditions, haploinsufficiencies, hepatic disease, channelopathies, endocrine disease, cardiovascular disease, reproductive disease, renal disease, skeletal muscle disease, bone disease, CNS disorders |
International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
Class Status Code | 6 - Active |
Class Status Date | Wednesday, March 30, 2022 |
Primary Code | 005 |
First Use Anywhere Date | NOT AVAILABLE |
First Use In Commerce Date | NOT AVAILABLE |
Party Name | Omega Therapeutics, Inc. |
Party Type | 10 - Original Applicant |
Legal Entity Type | 03 - Corporation |
Address | Cambridge, MA 02140 |
Event Date | Event Description |
Monday, May 8, 2023 | ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND |
Monday, May 8, 2023 | ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND |
Monday, May 8, 2023 | ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE |
Friday, January 20, 2023 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
Friday, January 20, 2023 | NON-FINAL ACTION E-MAILED |
Friday, January 20, 2023 | NON-FINAL ACTION WRITTEN |
Monday, January 9, 2023 | ASSIGNED TO EXAMINER |
Wednesday, March 30, 2022 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
Tuesday, March 29, 2022 | NEW APPLICATION ENTERED |